We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Contingency Management Treatment Duration (Duration)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00732342
First Posted: August 12, 2008
Last Update Posted: August 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by (Responsible Party):
UConn Health
  Purpose
310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted; (c) standard treatment with contingency management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted; or (d) standard treatment with contingency management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted. We expect that contingency management will decrease alcohol use to a greater extent than non-contingency management treatment, and that availability of contingency management for 24 weeks may result in longer term benefits than 12 week exposure to contingency management. This study will be the first to evaluate the effects of probability of winning prizes on response to contingency management.

Condition Intervention Phase
Alcohol Abuse Behavioral: Contingency Management Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Contingency Management Treatment Duration

Further study details as provided by UConn Health:

Primary Outcome Measures:
  • longest duration of negative breath samples submitted [ Time Frame: active phase and throughout follow-up phase ]

Secondary Outcome Measures:
  • subjective reports of alcohol use [ Time Frame: baseline and each follow-up ]

Enrollment: 310
Study Start Date: February 2008
Study Completion Date: May 2015
Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Standard Treatment
Experimental: 2
Standard Treatment with Contingency Management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence
Experimental: 3
Standard Treatment with Contingency Management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence
Experimental: 4
Standard Treatment with Contingency Management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 years
  • current DSM-IV diagnosis of alcohol abuse or dependence
  • willing to sign informed consent and able to pass an informed consent quiz

Exclusion Criteria:

  • serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
  • current DSM-IV diagnosis of opioid dependence
  • in recovery from pathological gambling
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00732342


Locations
United States, Connecticut
Prospect House
Bridgeport, Connecticut, United States, 06604
Alcohol and Drug Recovery Centers, Inc.
Hartford, Connecticut, United States, 06112
The Hospital of Central Connecticut at New Britain General
New Britain, Connecticut, United States, 06050
Morris Foundation
Waterbury, Connecticut, United States, 06702
United States, Massachusetts
Carlson Recovery Center
Springfield, Massachusetts, United States, 01199
Sponsors and Collaborators
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
Principal Investigator: Nancy M Petry, Ph.D. UConn Health
  More Information

Responsible Party: UConn Health
ClinicalTrials.gov Identifier: NCT00732342     History of Changes
Other Study ID Numbers: 08-053-2
P60AA003510 ( U.S. NIH Grant/Contract )
First Submitted: August 7, 2008
First Posted: August 12, 2008
Last Update Posted: August 18, 2015
Last Verified: August 2015

Keywords provided by UConn Health:
Alcohol Abuse
Contingency Management
Treatment Duration

Additional relevant MeSH terms:
Alcoholism
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders